MEDDPICC LTD


2022-04-012023-03-312023-03-31false13454213MEDDPICC LTD2023-06-2964209iso4217:GBPxbrli:pure134542132022-04-01134542132023-03-31134542132022-04-012023-03-31134542132021-06-14134542132022-03-31134542132021-06-142022-03-3113454213bus:SmallEntities2022-04-012023-03-3113454213bus:AuditExempt-NoAccountantsReport2022-04-012023-03-3113454213bus:FullAccounts2022-04-012023-03-3113454213bus:PrivateLimitedCompanyLtd2022-04-012023-03-3113454213core:WithinOneYear2023-03-3113454213core:AfterOneYear2023-03-3113454213core:WithinOneYear2022-03-3113454213core:AfterOneYear2022-03-3113454213core:ShareCapital2023-03-3113454213core:SharePremium2023-03-3113454213core:RevaluationReserve2023-03-3113454213core:OtherReservesSubtotal2023-03-3113454213core:RetainedEarningsAccumulatedLosses2023-03-3113454213core:ShareCapital2022-03-3113454213core:SharePremium2022-03-3113454213core:RevaluationReserve2022-03-3113454213core:OtherReservesSubtotal2022-03-3113454213core:RetainedEarningsAccumulatedLosses2022-03-3113454213core:LandBuildings2023-03-3113454213core:PlantMachinery2023-03-3113454213core:Vehicles2023-03-3113454213core:FurnitureFittings2023-03-3113454213core:OfficeEquipment2023-03-3113454213core:NetGoodwill2023-03-3113454213core:IntangibleAssetsOtherThanGoodwill2023-03-3113454213core:ListedExchangeTraded2023-03-3113454213core:UnlistedNon-exchangeTraded2023-03-3113454213core:LandBuildings2022-03-3113454213core:PlantMachinery2022-03-3113454213core:Vehicles2022-03-3113454213core:FurnitureFittings2022-03-3113454213core:OfficeEquipment2022-03-3113454213core:NetGoodwill2022-03-3113454213core:IntangibleAssetsOtherThanGoodwill2022-03-3113454213core:ListedExchangeTraded2022-03-3113454213core:UnlistedNon-exchangeTraded2022-03-3113454213core:LandBuildings2022-04-012023-03-3113454213core:PlantMachinery2022-04-012023-03-3113454213core:Vehicles2022-04-012023-03-3113454213core:FurnitureFittings2022-04-012023-03-3113454213core:OfficeEquipment2022-04-012023-03-3113454213core:NetGoodwill2022-04-012023-03-3113454213core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3113454213core:ListedExchangeTraded2022-04-012023-03-3113454213core:UnlistedNon-exchangeTraded2022-04-012023-03-3113454213core:MoreThanFiveYears2022-04-012023-03-3113454213core:Non-currentFinancialInstruments2023-03-3113454213core:Non-currentFinancialInstruments2022-03-3113454213dpl:CostSales2022-04-012023-03-3113454213dpl:DistributionCosts2022-04-012023-03-3113454213dpl:AdministrativeExpenses2022-04-012023-03-3113454213core:LandBuildings2022-04-012023-03-3113454213core:PlantMachinery2022-04-012023-03-3113454213core:Vehicles2022-04-012023-03-3113454213core:FurnitureFittings2022-04-012023-03-3113454213core:OfficeEquipment2022-04-012023-03-3113454213core:NetGoodwill2022-04-012023-03-3113454213core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3113454213dpl:GroupUndertakings2022-04-012023-03-3113454213dpl:ParticipatingInterests2022-04-012023-03-3113454213dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3113454213core:ListedExchangeTraded2022-04-012023-03-3113454213dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3113454213core:UnlistedNon-exchangeTraded2022-04-012023-03-3113454213dpl:CostSales2021-06-142022-03-3113454213dpl:DistributionCosts2021-06-142022-03-3113454213dpl:AdministrativeExpenses2021-06-142022-03-3113454213core:LandBuildings2021-06-142022-03-3113454213core:PlantMachinery2021-06-142022-03-3113454213core:Vehicles2021-06-142022-03-3113454213core:FurnitureFittings2021-06-142022-03-3113454213core:OfficeEquipment2021-06-142022-03-3113454213core:NetGoodwill2021-06-142022-03-3113454213core:IntangibleAssetsOtherThanGoodwill2021-06-142022-03-3113454213dpl:GroupUndertakings2021-06-142022-03-3113454213dpl:ParticipatingInterests2021-06-142022-03-3113454213dpl:GroupUndertakingscore:ListedExchangeTraded2021-06-142022-03-3113454213core:ListedExchangeTraded2021-06-142022-03-3113454213dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-06-142022-03-3113454213core:UnlistedNon-exchangeTraded2021-06-142022-03-3113454213core:NetGoodwill2023-03-3113454213core:IntangibleAssetsOtherThanGoodwill2023-03-3113454213core:LandBuildings2023-03-3113454213core:PlantMachinery2023-03-3113454213core:Vehicles2023-03-3113454213core:FurnitureFittings2023-03-3113454213core:OfficeEquipment2023-03-3113454213core:AfterOneYear2023-03-3113454213core:WithinOneYear2023-03-3113454213core:ListedExchangeTraded2023-03-3113454213core:UnlistedNon-exchangeTraded2023-03-3113454213core:ShareCapital2023-03-3113454213core:SharePremium2023-03-3113454213core:RevaluationReserve2023-03-3113454213core:OtherReservesSubtotal2023-03-3113454213core:RetainedEarningsAccumulatedLosses2023-03-3113454213core:NetGoodwill2022-03-3113454213core:IntangibleAssetsOtherThanGoodwill2022-03-3113454213core:LandBuildings2022-03-3113454213core:PlantMachinery2022-03-3113454213core:Vehicles2022-03-3113454213core:FurnitureFittings2022-03-3113454213core:OfficeEquipment2022-03-3113454213core:AfterOneYear2022-03-3113454213core:WithinOneYear2022-03-3113454213core:ListedExchangeTraded2022-03-3113454213core:UnlistedNon-exchangeTraded2022-03-3113454213core:ShareCapital2022-03-3113454213core:SharePremium2022-03-3113454213core:RevaluationReserve2022-03-3113454213core:OtherReservesSubtotal2022-03-3113454213core:RetainedEarningsAccumulatedLosses2022-03-3113454213core:NetGoodwill2021-06-1413454213core:IntangibleAssetsOtherThanGoodwill2021-06-1413454213core:LandBuildings2021-06-1413454213core:PlantMachinery2021-06-1413454213core:Vehicles2021-06-1413454213core:FurnitureFittings2021-06-1413454213core:OfficeEquipment2021-06-1413454213core:AfterOneYear2021-06-1413454213core:WithinOneYear2021-06-1413454213core:ListedExchangeTraded2021-06-1413454213core:UnlistedNon-exchangeTraded2021-06-1413454213core:ShareCapital2021-06-1413454213core:SharePremium2021-06-1413454213core:RevaluationReserve2021-06-1413454213core:OtherReservesSubtotal2021-06-1413454213core:RetainedEarningsAccumulatedLosses2021-06-1413454213core:AfterOneYear2022-04-012023-03-3113454213core:WithinOneYear2022-04-012023-03-3113454213core:Non-currentFinancialInstrumentscore:CostValuation2022-04-012023-03-3113454213core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-04-012023-03-3113454213core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-04-012023-03-3113454213core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-04-012023-03-3113454213core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-04-012023-03-3113454213core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-04-012023-03-3113454213core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3113454213core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3113454213core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3113454213core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3113454213core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3113454213core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3113454213core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3113454213core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3113454213core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3113454213core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3113454213core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3113454213core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3113454213core:Non-currentFinancialInstrumentscore:CostValuation2022-03-3113454213core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-3113454213core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-3113454213core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-3113454213core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-3113454213core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-3113454213core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-3113454213core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-3113454213core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-3113454213bus:Director12022-04-012023-03-3113454213bus:Director22022-04-012023-03-3113454213bus:Director32022-04-012023-03-3113454213bus:Director42022-04-012023-03-3113454213bus:Director52022-04-012023-03-3113454213bus:Director62022-04-012023-03-3113454213bus:Director72022-04-012023-03-31

MEDDPICC LTD

Registered Number
13454213
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2023

MEDDPICC LTD
Company Information
for the year from 1 April 2022 to 31 March 2023

Directors

BRAMBLE, Paul
CARROLL, Jack
LEE, Harry William
LUTON, Bradley Howard
MURPHY, Dean Edward
MURRAY, Ross Alexander
SALES, Daniel Marc

Registered Address

1 Gemini Court, 42a Throwley Way
Sutton
SM1 4AF

Registered Number

13454213 (England and Wales)
MEDDPICC LTD
Statement of Financial Position
31 March 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Investments53,736,1223,736,122
3,736,1223,736,122
Current assets
Cash at bank and on hand5,7599,490
5,7599,490
Creditors amounts falling due within one year8(1,940,803)(1,242,631)
Net current assets (liabilities)(1,935,044)(1,233,141)
Total assets less current liabilities1,801,0782,502,981
Creditors amounts falling due after one year9(1,178,703)(1,882,355)
Net assets622,375620,626
Capital and reserves
Called up share capital6,0006,000
Share premium594,000594,000
Profit and loss account22,37520,626
Shareholders' funds622,375620,626
  • The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
  • The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  • The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  • These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime. The directors have chosen to not file a copy of the company’s profit and loss account.
The financial statements were approved and authorised for issue by the Board of Directors on 29 June 2023, and are signed on its behalf by:
LUTON, Bradley Howard
Director
Registered Company No. 13454213
MEDDPICC LTD
Notes to the Financial Statements
for the year ended 31 March 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Accounting policies
Turnover policy
Turnover represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the value of the consideration due
Taxation policy
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Investments policy
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
4.Employee information

20232022
Average number of employees during the year77
5.Fixed asset investments

Other investments1

Total

££
Cost or valuation
At 01 April 223,736,1223,736,122
At 31 March 233,736,1223,736,122
Net book value
At 31 March 233,736,1223,736,122
At 31 March 223,736,1223,736,122

Notes

1Other investments other than loans
6.Description of nature of transactions and balances with related parties
During the year, management fees of £80,000 (2022: £45,000) were received from Cavey Dale Group Ltd, a subsidiary which is 100% owned by the company.
7.Further information regarding the company's financial position
The company's liabilities to Santander UK PLC are secured by way of fixed and floating charges on the company's assets.
8.Creditors within one year

2023

2022

££
Bank borrowings and overdrafts387,500387,500
Taxation and social security4104,866
Other creditors1,552,893850,265
Total1,940,8031,242,631
At the balance sheet date, included in other creditors an amount of £1,246,752 (2022:£531,233 ) was owed to Cavey Dale Group Ltd, a subsidiary which is 100% owned by the company. The loan is interest free and repayable on demand. At the balance sheet date, included in other creditors within one year, an amount of £387,500 was owed to Santander UK PLC. The amount is repayable by a quarterly capital repayment of £96,875 with a marginal interest rate of 4.15%.
9.Creditors after one year

2023

2022

££
Bank borrowings and overdrafts678,1251,065,625
Other creditors500,578816,730
Total1,178,7031,882,355
At the balance sheet date, included in creditors after one year, £500,578 (2022: £816,730) were for loan notes payable within more than 1 year. No interest shall be payable on the notes other than as may become payable. Monthly repayment amount is £26,346 and it is expected to be repaid fully by 15/10/2025. At the balance sheet date,included in creditors after one year, an amount of £678,125 (2022: £1,065,625) was owed to Santander UK PLC. The amount is repayable by a quarterly capital repayment of £96,875 with a marginal interest rate of 4.15%. The loan will be fully repaid by November 2025.